RHOEN-KLINIKUM AG (RHK.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:RHK - DE0007042301 - Common Stock
13.2 EUR
0 (0%)
Overall RHK gets a fundamental rating of 5 out of 10. We evaluated RHK against 30 industry peers in the Health Care Providers & Services industry. RHK is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. RHK is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- RHK had positive earnings in the past year.
- In the past year RHK had a positive cash flow from operations.
- RHK had positive earnings in each of the past 5 years.
- Each year in the past 5 years RHK had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 2.02%, RHK is in line with its industry, outperforming 43.33% of the companies in the same industry.
- RHK has a Return On Equity of 2.90%. This is in the lower half of the industry: RHK underperforms 63.33% of its industry peers.
- RHK's Return On Invested Capital of 2.67% is on the low side compared to the rest of the industry. RHK is outperformed by 70.00% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for RHK is below the industry average of 6.46%.
- The 3 year average ROIC (2.34%) for RHK is below the current ROIC(2.67%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.02% | ||
| ROE | 2.9% | ||
| ROIC | 2.67% |
ROA(3y)2%
ROA(5y)1.56%
ROE(3y)2.83%
ROE(5y)2.2%
ROIC(3y)2.34%
ROIC(5y)2.01%
1.3 Margins
- RHK has a Profit Margin (2.28%) which is in line with its industry peers.
- In the last couple of years the Profit Margin of RHK has declined.
- The Operating Margin of RHK (2.86%) is worse than 63.33% of its industry peers.
- RHK's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 66.81%, RHK is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
- RHK's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.86% | ||
| PM (TTM) | 2.28% | ||
| GM | 66.81% |
OM growth 3Y11.39%
OM growth 5Y-7.03%
PM growth 3Y10.42%
PM growth 5Y-3.92%
GM growth 3Y-1.4%
GM growth 5Y-0.67%
2. Health
2.1 Basic Checks
- RHK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- RHK has about the same amout of shares outstanding than it did 1 year ago.
- Compared to 5 years ago, RHK has about the same amount of shares outstanding.
- The debt/assets ratio for RHK has been reduced compared to a year ago.
2.2 Solvency
- RHK has an Altman-Z score of 3.09. This indicates that RHK is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of RHK (3.09) is better than 86.67% of its industry peers.
- RHK has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
- RHK has a Debt to Equity ratio of 0.09. This is amongst the best in the industry. RHK outperforms 96.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.09 |
ROIC/WACC0.4
WACC6.63%
2.3 Liquidity
- RHK has a Current Ratio of 2.28. This indicates that RHK is financially healthy and has no problem in meeting its short term obligations.
- RHK has a Current ratio of 2.28. This is amongst the best in the industry. RHK outperforms 93.33% of its industry peers.
- A Quick Ratio of 2.19 indicates that RHK has no problem at all paying its short term obligations.
- With an excellent Quick ratio value of 2.19, RHK belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.28 | ||
| Quick Ratio | 2.19 |
3. Growth
3.1 Past
- The earnings per share for RHK have decreased strongly by -15.41% in the last year.
- The Earnings Per Share has been growing slightly by 0.03% on average over the past years.
- RHK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.10%.
- The Revenue has been growing slightly by 4.12% on average over the past years.
EPS 1Y (TTM)-15.41%
EPS 3Y15.28%
EPS 5Y0.03%
EPS Q2Q%3.33%
Revenue 1Y (TTM)9.1%
Revenue growth 3Y4.41%
Revenue growth 5Y4.12%
Sales Q2Q%8.37%
3.2 Future
- Based on estimates for the next years, RHK will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.57% on average per year.
- RHK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.93% yearly.
EPS Next Y4.3%
EPS Next 2Y10.47%
EPS Next 3Y11.09%
EPS Next 5Y11.57%
Revenue Next Year6.74%
Revenue Next 2Y5.36%
Revenue Next 3Y6.5%
Revenue Next 5Y5.93%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- RHK is valuated rather expensively with a Price/Earnings ratio of 23.16.
- Based on the Price/Earnings ratio, RHK is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
- Compared to an average S&P500 Price/Earnings ratio of 27.21, RHK is valued at the same level.
- RHK is valuated rather expensively with a Price/Forward Earnings ratio of 17.27.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of RHK is on the same level as its industry peers.
- The average S&P500 Price/Forward Earnings ratio is at 24.26. RHK is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.16 | ||
| Fwd PE | 17.27 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, RHK is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 0.57 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RHK does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)5.38
PEG (5Y)680.99
EPS Next 2Y10.47%
EPS Next 3Y11.09%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.79%, RHK is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 1.73, RHK is paying slightly less dividend.
- With a Dividend Yield of 0.79, RHK pays less dividend than the S&P500 average, which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.79% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- RHK pays out 17.78% of its income as dividend. This is a sustainable payout ratio.
DP17.78%
EPS Next 2Y10.47%
EPS Next 3Y11.09%
RHOEN-KLINIKUM AG / RHK.DE FAQ
Can you provide the ChartMill fundamental rating for RHOEN-KLINIKUM AG?
ChartMill assigns a fundamental rating of 5 / 10 to RHK.DE.
What is the valuation status of RHOEN-KLINIKUM AG (RHK.DE) stock?
ChartMill assigns a valuation rating of 2 / 10 to RHOEN-KLINIKUM AG (RHK.DE). This can be considered as Overvalued.
Can you provide the profitability details for RHOEN-KLINIKUM AG?
RHOEN-KLINIKUM AG (RHK.DE) has a profitability rating of 4 / 10.
Can you provide the financial health for RHK stock?
The financial health rating of RHOEN-KLINIKUM AG (RHK.DE) is 7 / 10.
How sustainable is the dividend of RHOEN-KLINIKUM AG (RHK.DE) stock?
The dividend rating of RHOEN-KLINIKUM AG (RHK.DE) is 2 / 10 and the dividend payout ratio is 17.78%.